Literature DB >> 19144452

Synthesis, pharmacological evaluation and docking studies of new sulindac analogues.

Nelilma C Romeiro1, Ramon D F Leite, Lidia M Lima, Suzana V S Cardozo, Ana L P de Miranda, Carlos A M Fraga, Eliezer J Barreiro.   

Abstract

This paper describes the synthesis, pharmacological evaluation and docking studies of a series of new sulindac analogues. Overall, the designed compounds revealed good, in vivo, antinociceptive activity and satisfactory anti-inflammatory profile. Flexible molecular docking with COX-1/COX-2 has shown putative binding modes of the designed compounds while the theoretical evaluation of cell permeability based on Lipinski's rule of five has helped rationalize the biological results.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19144452     DOI: 10.1016/j.ejmech.2008.11.012

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  4 in total

1.  Target delivery and controlled release of the chemopreventive drug sulindac by using an advanced layered double hydroxide nanomatrix formulation system.

Authors:  Keiji Minagawa; Mohamed R Berber; Inas H Hafez; Takeshi Mori; Masami Tanaka
Journal:  J Mater Sci Mater Med       Date:  2012-02-18       Impact factor: 3.896

2.  Sulindac acetohydrazide derivative attenuates against cisplatin induced organ damage by modulation of antioxidant and inflammatory signaling pathways.

Authors:  Suhail Razak; Tayyaba Afsar; Nousheen Bibi; Mahmoud Abulmeaty; Mashooq Ahmad Bhat; Anam Inam; Janeen H Trembley; Ali Almajwal; Maria Shabbir; Nawaf W Alruwaili; Abdulrahman Algarni
Journal:  Sci Rep       Date:  2022-07-11       Impact factor: 4.996

3.  Cyclooxygenase-1-selective inhibitors based on the (E)-2'-des-methyl-sulindac sulfide scaffold.

Authors:  Andy J Liedtke; Brenda C Crews; Cristina M Daniel; Anna L Blobaum; Philip J Kingsley; Kebreab Ghebreselasie; Lawrence J Marnett
Journal:  J Med Chem       Date:  2012-02-14       Impact factor: 7.446

4.  Novel sulindac derivatives: synthesis, characterisation, evaluation of antioxidant, analgesic, anti-inflammatory, ulcerogenic and COX-2 inhibition activity.

Authors:  Mashooq A Bhat; Mohamed A Al-Omar; Nawaf A Alsaif; Abdulrahman A Almehizia; Ahmed M Naglah; Suhail Razak; Azmat Ali Khan; Naeem Mahmood Ashraf
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.